PMID- 29502187 OWN - NLM STAT- MEDLINE DCOM- 20190510 LR - 20190510 IS - 1862-3514 (Electronic) VI - 13 IP - 1 DP - 2018 Mar 3 TI - Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients. PG - 15 LID - 10.1007/s11657-018-0432-x [doi] AB - This study analyzed data on 87,224 osteoporotic patients with up to 18 years of computerized medical history. Patients with osteoporosis and type 2 diabetes had higher bone density yet more fractures than non-diabetic osteoporotic patients. Fracture incidence among the diabetic patients was associated with retinopathy and cardiovascular disease, but not with diabetes duration. PURPOSE: Little is known about the association between type 2 diabetes mellitus (T2DM) and fragility fractures or the mechanism(s) involved. We examined fracture correlates among T2DM patients with osteoporosis. METHODS: We used electronic health records of an osteoporosis (OP) registry cross-linked with a diabetes registry of a large payer provider healthcare organization in Israel. A cross-sectional analysis compared osteoporosis patients with and without T2DM, and a longitudinal Cox proportional hazard regression was used to identify incident fracture correlates. RESULTS: As of December 2015 a total of 87,224 current OP patients were identified, of whom 15,700 (18%) had T2DM. The T2DM OP patients were characterized by older age (mean 74.6 vs. 69.5), more males (20.3 vs. 14.0%), and a higher rate of chronic comorbidities compared to OP without diabetes. All major OP fractures (hip, spine, humerus, and forearm) were significantly more prevalent among T2DM OP patients (44 vs. 32%), with an overall age-standardized ratio of 1.22 (95% CI 1.19 to 1.25) and 1.15 (95% CI 1.10 to 1.21) for females and males respectively. The average T-scores were higher (femur neck - 1.8 vs. - 1.9, total hip - 1.2 vs. - 1.6, and vertebrae - 1.3 vs. - 1.7) for the T2DM OP patients compared to the non-T2DM OP patients. Among women with coexisting T2DM and osteoporosis (n = 10,812), fracture incidence was significantly associated with retinopathy (HR = 1.24, 95% CI 1.05 to 1.47) and cardiovascular disease (HR = 1.22, 95% CI 1.10 to 1.36) after controlling for age, bone mineral density T-score, rheumatoid arthritis, glucocorticoids, alcohol, and smoking). CONCLUSION: This large population-based study confirms the higher fracture risk of osteoporotic patients with T2DM, as compared to osteoporotic patients without T2DM, despite higher bone mineral density levels. The presence of micro- and macrovascular disease appears to increase this risk. FAU - Goldshtein, Inbal AU - Goldshtein I AD - Epidemiology & Database Research Unit, Maccabi Healthcare Services, Koyfman 4, Tel Aviv, Israel. goldst_in@mac.org.il. FAU - Nguyen, Allison Martin AU - Nguyen AM AD - Merck & Co Inc., North Wales, PA, USA. FAU - dePapp, Anne E AU - dePapp AE AD - Merck & Co Inc., North Wales, PA, USA. FAU - Ish-Shalom, Sofia AU - Ish-Shalom S AD - Endocrine Clinic, Elisha Hospital, Haifa, Israel. FAU - Chandler, Julie M AU - Chandler JM AD - Merck & Co Inc., North Wales, PA, USA. FAU - Chodick, Gabriel AU - Chodick G AD - Epidemiology & Database Research Unit, Maccabi Healthcare Services, Koyfman 4, Tel Aviv, Israel. FAU - Shalev, Varda AU - Shalev V AD - Epidemiology & Database Research Unit, Maccabi Healthcare Services, Koyfman 4, Tel Aviv, Israel. LA - eng PT - Journal Article DEP - 20180303 PL - England TA - Arch Osteoporos JT - Archives of osteoporosis JID - 101318988 SB - IM MH - Aged MH - Bone Density MH - Comorbidity MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2/diagnosis/epidemiology/metabolism MH - Female MH - Humans MH - Incidence MH - Israel/epidemiology MH - Male MH - Middle Aged MH - *Osteoporosis/diagnosis/epidemiology/metabolism MH - *Osteoporotic Fractures/classification/diagnosis/epidemiology/metabolism MH - Prevalence MH - Registries/statistics & numerical data MH - Risk Factors OTO - NOTNLM OT - Complications OT - Fracture OT - Osteoporosis OT - Type 2 diabetes mellitus EDAT- 2018/03/05 06:00 MHDA- 2019/05/11 06:00 CRDT- 2018/03/05 06:00 PHST- 2017/08/07 00:00 [received] PHST- 2018/02/04 00:00 [accepted] PHST- 2018/03/05 06:00 [entrez] PHST- 2018/03/05 06:00 [pubmed] PHST- 2019/05/11 06:00 [medline] AID - 10.1007/s11657-018-0432-x [pii] AID - 10.1007/s11657-018-0432-x [doi] PST - epublish SO - Arch Osteoporos. 2018 Mar 3;13(1):15. doi: 10.1007/s11657-018-0432-x.